Share：
Share this content in WeChat
X
[Chinese][PDF]55379
• Experience Exchang •
Application of in-phase and out-of-phase imaging in the grading of gliomas
QU Yuan  ZHOU Lisui  WANG Yan  QUAN Guangnan 

Cite this article as: Qu Y, Zhou LS, Wang Y, et al. Application of in-phase and out-of-phase imaging in the grading of gliomas[J]. Chin J Magn Reson Imaging, 2022, 13(1): 103-105. DOI:10.12015/issn.1674-8034.2022.01.020.


[Abstract] Objective To evaluate the diagnostic value of in-phase and out-of-phase imaging in in grading gliomas.Materials and Methods: A total of 74 patients with glioma confirmed by pathology were retrospectively analyzed. All patient underwent contrast enhanced imaging and in-phase and out-of-phase before the operation. The signal loss ratio (SLR) of the solid part of the glioma was calculated on the in-phase and out-of-phase imaging. The difference of SLR between high-grade glioma (HGG) and low-grade glioma (LGG) was compared, and receiver operating characteristic (ROC) curve was used to evaluate the grading performance of SLR value.Results The SLR value of HGG was higher than that of LGG, which was statistically different (P＜0.05). The area under curve (AUC) value of SLR to differentiate HGG and LGG was 0.895.Conclusions In-phase and out-of-phase imaging can help the grading of gliomas. It is simple and easy to implement, and has good clinical practical value.
[Keywords] glioma；grading；magnetic resonance imaging；in-phase and out-of-phase imaging；signal loss ratio

QU Yuan1   ZHOU Lisui2   WANG Yan1*   QUAN Guangnan3  

1 Department of MR, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China

2 Department of Radiology, Chengdu University Affiliated Hospital, Chengdu 610081, China

3 GE Healthcare China, Beijing 100176, China

Wang Y, E-mail: drwangxj@sina.cn

Conflicts of interest   None.

ACKNOWLEDGMENTS General Project of Natural Science Foundation of Xinjiang Uygur Autonomous Region (No. 2019D01C157).
Received  2021-07-15
Accepted  2021-12-17
DOI: 10.12015/issn.1674-8034.2022.01.020
Cite this article as: Qu Y, Zhou LS, Wang Y, et al. Application of in-phase and out-of-phase imaging in the grading of gliomas[J]. Chin J Magn Reson Imaging, 2022, 13(1): 103-105. DOI:10.12015/issn.1674-8034.2022.01.020.

[1]
Shetty AS, Sipe AL, Zulfiqar M, et al. In-phase and opposed-phase imaging: applications of chemical shift and magnetic susceptibility in the chest and abdomen[J]. Radiographics, 2019, 39(1): 115-135. DOI: 10.1148/rg.2019180043.
[2]
Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary[J]. Acta Neuropathol, 2016, 131(6): 803-820. DOI: 10.1007/s00401-016-1545-1.
[3]
Baenke, F, Peck, B, Miess, H, et al. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumor development[J]. Dis Model Mech, 2013, 6(6): 1353-1363. DOI: 10.1242/dmm.011338.
[4]
De Pardieu M, Boucebci S, Herpe G, et al. Glioma-grade diagnosis using in-phase and out-of-phase T1-weighted magnetic resonance imaging: A prospective study[J]. Diagn Interv Imaging, 2020, 101(7): 451-456. DOI: 10.1016/j.diii.2020.04.013.
[5]
Suh CH, Kim HS, Park JE, et al. Comparative value of 2-hydroxyglutarate-to-lipid and lactate ratio versus 2-hydroxyglutarate concentration on MR spectroscopic images for predicting isocitrate dehydrogenase mutation status in gliomas. Radiol Imaging Cancer[J]. 2020, 2(4): e190083. DOI: 10.1148/rycan.2020190083.
[6]
Xiao GQ, Wang ST, Xu FL, et al. Value of DWI combined with MRS in glioma grade diagnosis[J]. Chin J Magn Reson Imaging, 2020, 97(7): 573-576. DOI: 10.12015/issn.1674-8034.2020.07.019.
[7]
Zhang XX, Li YH. Application of magnetic resonance imaging in preoperative glioma grading[J]. Chin Comput Med Imag, 2019, 25(3): 326-331. DOI: 10.19627/j.cnki.cn31-1700/th.2019.03.025.
[8]
Askari P, Dimitrov IE, Ganji SK, et al. Spectral fitting strategy to overcome the overlap between 2-hydroxyglutarate and lipid resonances at 2.25 ppm[J]. Magn Reson Med. 2021, 86(4):1818-1828. DOI: 10.1002/mrm.28829.
[9]
Lim CJ, Ng KH, Ramli N, et al. Evaluation of the application of chemical shift for the detection of lipid in brain lesion[J]. Radiography, 2011, 17(10): 43-48. DOI: 10.1016/j.radi.2010.10.003.
[10]
Ramli N, Khairy AM, Seow P, et al. Novel application of chemical shift gradient echo in-and opposed-phase sequences in 3 T MRI for the detection of H-MRS visible lipids and grading of glioma[J]. Eur Radiol, 2016, 26(7): 2019-2029. DOI: 10.1007/s00330-015-4045-0.
[11]
Seow P, Narayanan V, Hernowo AT, et al. Quantification and visualization of lipid landscape in glioma using in-and opposed-phase imaging[J]. Neuroimage Clin, 2018, 20(8): 531-536. DOI: 10.1016/j.nicl.2018.08.003.
[12]
Meisamy S, Hines CD, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy[J]. Radiology, 2011, 258(2): 767-775. DOI: 10.1148/radiol.10100708.
[13]
Kim HJ, Cho HJ, Kim B, et al. Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: a phantom and human study[J]. J Magn Reson Imaging, 2019, 50(1): 305-314. DOI: 10.1002/jmri.26575.
[14]
Seow P, Narayanan V, Romelean RJ, et al. Lipid fraction derived from MRI In-and Opposed-Phase sequence as a novel biomarker for predicting survival outcome of glioma[J]. Acad Radiol. 2020, 27(2):180-187. DOI: 10.1016/j.acra.2019.04.015.
[15]
Wenger KJ, Steinbach JP, Bähr O, et al. Lower lactate levels and lower lntracellular pH in patients with IDH-Mutant versus Wild-Type gliomas[J]. AJNR Am J Neuroradiol. 2020, 41(8): 1414-1422. DOI: 10.3174/ajnr.A6633.

PREV The effect of bandwidth on evaluation of T1, T2 relaxation times and proton density using synthetic MRI: A phantom study
NEXT Functional connectivity of paraventricular thalamus in nocturnal enuresis: a rs-fMRI study
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn